Johnson & Johnson, a global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify druggable targets in Chronic Kidney Disease and... read more →
Johnson & Johnson, a global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations, wishes to identify druggable targets in progressive fibrosing interstitial lung... read more →
A multinational biopharmaceutical company with long-standing presence in rheumatology and more recently, immuno-dermatology and bone disorders, are interested in the musculoskeletal area by exploring further indications in this space.
A global biotechnology company interested in both small-molecule and biologics platforms demonstrating therapeutics activity in the field of oncology is seeking Technologies, Research Projects, Spinout Companies and Engagement with Academic... read more →